Brief: Avrobio Announces Preclinical Gene Therapy Data For Pompe Disease At ASGCT Annual Meeting

Tectonic Therapeutic

18/05/2022 12:24

May 18 (Reuters) - AVROBIO Inc  AVRO.O :
    * AVROBIO ANNOUNCES PRECLINICAL GENE THERAPY DATA FOR POMPE DISEASE AT
AMERICAN
SOCIETY OF GENE AND CELL THERAPY (ASGCT) ANNUAL MEETING
    * AVROBIO INC - DATA SUPPORT PLANS TO INITIATE CLINICAL TRIAL IN 2023
    * AVROBIO INC - SUBSTANTIAL REDUCTION IN GLYCOGEN OBSERVED ACROSS CARDIAC
AND
SKELETAL MUSCLES, AS WELL AS CNS

Source text for Eikon:  ID:nBw9FT2gTa 
Further company coverage:  AVRO.O 

 ((Reuters.Briefs@thomsonreuters.com;))